CAR-T cell therapy is already a potent treatment for certain cancers. Now, a small study is showing early promise for ...

By Deena Beasley May 11 (Reuters) - Re-engineering an HIV patient's own immune cells to find and destroy the virus succeeded ...

An HIV expert at the University of California, San Francisco, presented evidence this week of a major advance in the search ...

Researchers from Queen Mary University of London have uncovered a previously unknown mechanism by which HIV-1 can infect ...

The column answers questions on post-abortion sensitivity, orgasms and the importance of STI testing before marriage ...

Researchers mapped more than 100 mutations that allow diverse HIV-1 strains to evade broadly neutralizing antibodies.

HIV-1 remodels the spatial organization of its co-receptor, CXCR4, on T cell membranes, showing that viral entry requires receptor clustering rather than simple receptor binding.

Larger and longer studies needed to prove that CAR-T therapy can really offer long-lasting ...

Broadly neutralizing antibodies (bNAbs) are among the most promising new treatments for HIV, offering the potential to forego traditional daily dose of antiretroviral drugs.